+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multidrug-resistant Gram-negative bacteria in postoperative infections



Multidrug-resistant Gram-negative bacteria in postoperative infections



Journal of the Indian Medical Association 107(3): 148-50, 163



Gram-negative bacteria are responsible in an important way in hospital-associated infections and their reported resistance to multiple antimicrobials is a matter of grave concern. In this study, Gram-negative bacteria isolated from clinical samples of postoperative infected patients were identified and their antibiotic susceptibility patterns determined. The prevalence of multidrug-resistant Gram-negative bacteria was 9.45% and the highest prevalence was seen in GI surgery department. Escherichia coli and klebsiella were the most common bacterial isolates. Amongst the 14 antibiotics tested, the percentage sensitivity against the multidrug-resistant Gram-negative isolates was highest for amikacin, meropenem, piperacillin + tazobactam and cefoperazone + sulbactam.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054489694

Download citation: RISBibTeXText

PMID: 19810380


Related references

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005. Clinical Microbiology and Infection 14(1): 93-96, 2007

Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infection Control and Hospital Epidemiology 38(7): 848-856, 2017

Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. American Journal of Transplantation 13 Suppl 4: 31-41, 2013

Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections. Antimicrobial Agents and ChemoTherapy 61(3), 2016

Add-On Therapy with Ertapenem in Infections with Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience. Case Reports in Infectious Diseases 2017: 8096420-8096420, 2017

Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria. Cleveland Clinic Journal of Medicine 74 Suppl 4: S12-S20, 2007

Investigational drugs for the treatment of infections caused by multidrug-resistant gram-negative bacteria. Expert Opinion on Investigational Drugs, 2018

Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients. World Journal of Critical Care Medicine 5(2): 111-120, 2016

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. Journal of Infection 56(3): 185-190, 2008

Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward "molecularly targeted" therapy. Expert Review of Anti-Infective Therapy, 2018

Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection. American Journal of Infection Control (): -, 2016

Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. Journal of Clinical Pharmacy and Therapeutics 39(3): 272-276, 2015

Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital. Journal of the Medical Association of Thailand 97 Suppl 3(): S35-S45, 2014

Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria. International Journal of Antimicrobial Agents 31(1): 80-82, 2007

Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria. Expert Review of Anti-Infective Therapy 12(4): 471-478, 2015